Published 05:20 IST, April 24th 2020
UK records 616 more COVID-19 deaths, total at 18,738 as NHS struggles against the pandemic
The UK health ministry on April 23 has reported nearly 616 more coronavirus deaths, taking the country's death toll to 18,738 with over 138,078 active cases.
Advertisement
United Kingdom health ministry on Thursday, April 23 reported nearly 616 more coronavirus deaths, taking country's death toll to 18,738. Though daily rise in toll was lower than previous days, UK is still struggling to contain dely outbreak of virus. According to Worldometer, UK has over 138,078 active COVID-19 cases out of which nearly 1,559 are in critical condition.
With virus still wreaking havoc in country, UK Health Secretary Matt Hancock informed that authorities have set a '100,000 coronavirus tests' which will be carried out daily from end of this month. While dressing daily coronavirus briefing, he ded that testing capacity has also increased to 51,000 a day because of ‘test, track and trace’ formula.
Advertisement
Furrmore, Hancock also informed that any essential worker who needs a test will be able to book an appointment on gov.uk mselves from April 24.
Advertisement
‘Vaccine Taskforce’
In a bid to overcome COVID-19 infection, last week UK government also anunced a ‘Vaccine Taskforce’ which will drive forward, expedite and co-ordinate efforts to research and produce a coronavirus vaccine. According to official UK government website, taskforce will be led by Chief Scientific viser Sir Patrick Vallance and Deputy Chief Medical Officer Professor Jonathan Van-Tam.
authorities will be supporting efforts to develop a COVID-19 vaccine as soon as possible by providing industry and research institutions with required resources and support. y will be reviewing regulations and scaling up manufacturing so that when vaccine becomes available, it can be produced at a quick pace and in mass quantities.
Advertisement
Furrmore, authorities also anunced that 21 new coronavirus research projects will benefit from accumulated funding, worth around £14 million (about $17,2 million).
Advertisement
authorities have also invited GP surgeries to take part in ‘ground-breaking trial’, to ascertain wher it could reduce need for affected patients to go to hospital and speed up ir recovery. Furrmore, government also anunced one new project led by University of Oxford, in which y will trial anti-malarial drug to determine wher it could diminish effects of COVID-19 on people in identified high-risk groups.
(Im source: AP)
Advertisement
04:25 IST, April 24th 2020